Trial Profile
A Phase I Study of Weekly Topotecan With Cisplatin for the Management of Advanced Stage or Recurrent Carcinoma of the Cervix
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 22 Aug 2023
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Topotecan (Primary)
- Indications Cervical cancer
- Focus Adverse reactions
- 14 Feb 2008 Status change from recruiting to discontinued due to low accrual, as reported by clinicaltrials.gov.
- 13 Nov 2006 New trial record.